Suppr超能文献

人异亮氨酸-丝氨酸-缓激肽与大鼠T-激肽相同,是卵巢癌腹水的主要渗透因子。

Human Ile-Ser-bradykinin, identical with rat T-kinin, is a major permeability factor in ovarian carcinoma ascites.

作者信息

Wunderer G, Walter I, Müller E, Henschen A

出版信息

Biol Chem Hoppe Seyler. 1986 Dec;367(12):1231-4. doi: 10.1515/bchm3.1986.367.2.1231.

Abstract

Ascites from patients with metastatic ovarian carcinoma contains high amounts of an activity that increases vascular permeability, as easily detected by a rat skin test. Ascites was fractionated by gel permeation and reversed-phase high-performance liquid chromatographies. The fractions were analysed for permeability-increasing activity. In this way a peptide was isolated and identified as Ile-Ser-bradykinin by sequence and amino-acid analyses. It is identical with T-kinin which has previously been detected as a product of an acute-phase protein, T-kininogen, in rats but never in human material. The so far identified human kininogens, i.e. high- and low-molecular mass kininogens, can only release Met-Lys-bradykinin or its degradations products, as Ile-Ser-bradykinin is not a part of their structure. However, the present results provide evidence that the permeability factor Ile-Ser-bradykinin under certain conditions can be produced in considerable amounts also by human tissues.

摘要

转移性卵巢癌患者的腹水中含有大量可增加血管通透性的活性物质,通过大鼠皮肤试验可轻易检测到。腹水通过凝胶渗透和反相高效液相色谱进行分级分离。对各馏分进行增加通透性活性分析。通过这种方式分离出一种肽,并通过序列和氨基酸分析鉴定为异亮氨酸 - 丝氨酸 - 缓激肽。它与T - 激肽相同,T - 激肽先前在大鼠中被检测为急性期蛋白T - 激肽原的产物,但从未在人类材料中检测到。迄今为止已鉴定的人类激肽原,即高分子量和低分子量激肽原,只能释放甲硫氨酸 - 赖氨酸 - 缓激肽或其降解产物,因为异亮氨酸 - 丝氨酸 - 缓激肽不是它们结构的一部分。然而,目前的结果提供了证据,表明在某些条件下,人类组织也可以大量产生通透性因子异亮氨酸 - 丝氨酸 - 缓激肽。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验